Innovation
all about
innovation
The wellbeing of those affected by central nervous system disorders is at the very heart of all we do. Our research and innovation efforts are dedicated to developing improved and better adapted pharmaceutical forms, as well as new and innovative therapeutic solutions to meet the needs of those experiencing psychiatric and neurological disorders.
Through continuously investing in research and exploring new strategic industry alliances, we seek to unlock new possibilities, push boundaries and transform the healthcare landscape to provide the most effective CNS therapies.
CNS specialist
finding solutions for CNS disorders
Expertise by experience
Neuraxpharm has 40 years of specialist experience in finding solutions for disorders related to the central nervous system.
The scientific work of our R&D department is led by our highly qualified and experienced team at Neuraxpharm HealthTech, our center of excellence for innovation.
With strong scientific capabilities primarily focused on higher value projects, we are constantly innovating to develop new solutions for the market that address the challenging unmet needs of our CNS patients.
Our R&D services provide expertise in:
Dedication that breeds results
The dedication of our R&D teams is reflected in the growing number of products supplied and distributed all over the world and in the loyalty of our clients.
We are proud to be able to share some of our teams’ achievements:
Our approach to fuel our pipeline
We have a strong track record for continuously enriching our pipeline with a selection of new projects to improve the lives of patients with CNS conditions through research and development (R&D), business development (BD), and mergers and acquisitions (M&A).
Additionally, we are successfully launching and growing our innovative CNS solutions in Europe.
R&D
Team focused on own development
BD
Partnership for licences & Co-development
M&A
Mergers & Acquisitions of products and companies
Our pipeline
Neuraxpharm is constantly innovating new products and solutions to address unmet patient needs and is expanding its CNS product portfolio through its pipeline, partnerships and acquisitions.
With its focus towards more innovative treatments, Neuraxpharm develops and commercializes generics, value added medicines, originator brands, orphan drugs, beyond-the-pill solutions and biologic drugs. The company continuously strives to offer a wide range of effective, high quality, and affordable treatment options for chronic, severe, standard and “mild” CNS disorders.
Our current pipeline has more than 25 projects, all focused on CNS, and perfectly reflects our commitment to addressing unmet needs, offering innovative solutions, and a fresh approach to biologics. We continue to seek opportunities to expand our pipeline.
Here are our product candidates in neurology and psychiatry, along with their current status (1S/2025) in our pipeline.
